A

Amgen

Makes biotech medicines for serious illnesses

Director Global Value & Access Business Development

Corporate StrategyConfirmed live in the last 24 hours
Full-timeRemote in USARemote

About the Job

Requirements

  • A doctorate degree and 4 years of market access or payer experience, including business experience in a role aligned with a Marketing/Sales commercial organization; or a master's degree and 7 years of such experience; or a bachelor's degree and 9 years of such experience.
  • Strong understanding of the United States and ex-United States payer environment and drug pricing and reimbursement economics across payer segments and channels for oral and injectable assets.
  • Strong analytical skills to evaluate access and pricing risks and opportunities of potential business-development target assets.
  • Ability to work under pressure and tight timelines, make assumptions with limited data, and collaborate across partners in the business-development process.

Responsibilities

  • Serve as the Global Value & Access point of contact for pricing, access, and coverage assumptions within business-development commercial assessments, coordinating with regional and country Value & Access and cross-functional partners to align assumptions.
  • Drive fit-for-purpose research on business-development targets using key databases such as Navlin, Analysource, IQVIA MIDAS, AlphaSense, DRG, MMIT, and CMS Medicare, as well as business-development diligence materials, to research target products, key analogs, and competitors.
  • Work with the Operational Pricing team and external agencies on secondary and primary payer research, and research, evaluate, and collaborate with internal teams on background material related to business-development targets before finalizing inputs.
  • Provide price and access assumptions for business-development revenue forecasts based on target product profiles and scenario sensitivities.
  • Lead cross-functional teams on key pricing and access risks and opportunities for product strategy and revenue forecasts.
  • Participate in deal governance and project meetings to align Global Value & Access inputs with cross-functional assessments, timelines, and key decision points for business-development projects.
  • Lead strategic projects and/or serve as Access Strategy Lead for internal early-pipeline products.

Desired Qualifications

  • Manage effectively in a highly fluid, interactive, matrix environment and build strong business partnerships with regional and global colleagues.
  • Translate complex analyses of the external pricing and reimbursement environment and potential assets into relevant analytic questions.
  • Translate analytic output into potential price and access opportunities for potential deals, quantifying impact for Amgen, providers, patients, and payers.
  • Apply strategic thinking to translate analytic output into business-driving insights and proactively define and develop capabilities for success in a changing environment.
  • Bring structure to vaguely defined problems, pragmatically scope problem-solving approaches, and manage execution.
  • Demonstrate strong pricing and access technical skills and fluency with data analysis and market research.
  • Demonstrate strong oral and written communication and interpersonal skills, with credible senior-management presence and the ability to communicate at all organizational levels.
  • Understand the United States and global payer environment, including coverage and reimbursement, pricing, value drivers, formulary management, health technology assessment, and health policy.
  • Have deep understanding of the United States government and commercial reimbursement environment and experience in United States Market Access, such as Contracts & Pricing or Payer Marketing, or adjacent Global Market Access or Market Access Consulting experience with deep United States expertise.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs